Kimba
Elevating Health and Sleep Through AI and Scent Technology
Company Overview
Snapshot
Founded in January 2024 by Ben Fuxbruner and Gabi Beck, Kimba operates with 1–10 employees. The company has raised $6.5 million across two funding rounds from seven investors.
Business overview
Kimba develops scent-based personal limbic therapy, leveraging AI to analyze biometric data and deliver personalized scent therapy. This technology aims to improve sleep and overall health, particularly for individuals suffering from sleep disorders and mental health challenges. The company operates within the Health Tech & Life Sciences sector, with a focus on medical devices, and serves patients and consumers in the healthcare and recreational & lifestyle markets.
Strategic signal
In June 2026, Kimba emerged from stealth, revealing its AI-powered personalized scent therapy system designed to improve sleep quality and recovery. This signals a significant step in the company's market entry and validation of its innovative approach to health and wellness, particularly targeting individuals with sleep issues, including veterans with PTSD. The announcement highlights Kimba's readiness to commercialize its technology and attract further investment and partnerships in the health tech space.
Log in to access full profile ›Company Intelligence Q&A
- When was Kimba founded?
- Kimba was founded in January 2024.
- Who are the founders of Kimba?
- Kimba was co-founded by Ben Fuxbruner, who serves as CEO, and Gabi Beck, who is the CTO.
- What is Kimba's primary focus?
- Kimba focuses on developing AI-powered, scent-based personal limbic therapy to analyze biometric data and provide personalized scent therapy for improving sleep and health.